<i>Health Technology Assessment</i> del vaccino ricombinante adiuvato contro il virus respiratorio sinciziale (Arexvy<sup>®</sup>).
- DOI
- 10.15167/2421-4248/jpmh2024.65.2s1
- Published
- 2024-06-30
- Container
- J Prev Med Hyg
- Publisher
- Journal of Preventive Medicine and Hygiene
- Open access
- yes
Credibility signals
uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.15167/2421-4248/jpmh2024.65.2s1,
title = {<i>Health Technology Assessment</i> del vaccino ricombinante adiuvato contro il virus respiratorio sinciziale (Arexvy<sup>®</sup>).},
author = {Calabrò GE and Rizzo C and Domnich A and DE Waure C and Rumi F and Bonanni P and Boccalini S and Bechini A and Panatto D and Amicizia D and Amodio E and Costantino C and Bert F and Lo Moro G and DI Pietro ML and Giuffrida S and Giordano V and Conversano M and Russo C and Spadea A and Ansaldi F and Grammatico F and Ricciardi R and Torrisi M and Porretta AD and Arzilli G and Scarpaleggia M and Bertola C and Vece M and Lupi C and Lorenzini E and Massaro E and Tocco M and Trapani G and Zarcone E and Munno L and Zace D and Petrella L and Vitale F and Ricciardi W.},
year = {2024},
journal = {J Prev Med Hyg},
doi = {10.15167/2421-4248/jpmh2024.65.2s1},
url = {https://doi.org/10.15167/2421-4248/jpmh2024.65.2s1}
}RIS
TY - JOUR TI - <i>Health Technology Assessment</i> del vaccino ricombinante adiuvato contro il virus respiratorio sinciziale (Arexvy<sup>®</sup>). AU - Calabrò GE AU - Rizzo C AU - Domnich A AU - DE Waure C AU - Rumi F AU - Bonanni P AU - Boccalini S AU - Bechini A AU - Panatto D AU - Amicizia D AU - Amodio E AU - Costantino C AU - Bert F AU - Lo Moro G AU - DI Pietro ML AU - Giuffrida S AU - Giordano V AU - Conversano M AU - Russo C AU - Spadea A AU - Ansaldi F AU - Grammatico F AU - Ricciardi R AU - Torrisi M AU - Porretta AD AU - Arzilli G AU - Scarpaleggia M AU - Bertola C AU - Vece M AU - Lupi C AU - Lorenzini E AU - Massaro E AU - Tocco M AU - Trapani G AU - Zarcone E AU - Munno L AU - Zace D AU - Petrella L AU - Vitale F AU - Ricciardi W. PY - 2024 JO - J Prev Med Hyg DO - 10.15167/2421-4248/jpmh2024.65.2s1 UR - https://doi.org/10.15167/2421-4248/jpmh2024.65.2s1 ER -
APA
GE, C., C, R., A, D., C, D. W., F, R., P, B., S, B., A, B., D, P., D, A., E, A., C, C., F, B., G, L. M., ML, D. P., S, G., V, G., M, C., C, R., A, S., F, A., F, G., R, R., M, T., AD, P., G, A., M, S., C, B., M, V., C, L., E, L., E, M., M, T., G, T., E, Z., L, M., D, Z., L, P., F, V., & W., R. (2024). <i>Health Technology Assessment</i> del vaccino ricombinante adiuvato contro il virus respiratorio sinciziale (Arexvy<sup>®</sup>).. J Prev Med Hyg. https://doi.org/10.15167/2421-4248/jpmh2024.65.2s1
Source records
- europe-pmc · retrieved 2026-09-26T07:04:52.518Z
- datacite · retrieved 2026-09-26T07:04:52.486Z